Thank you to everyone involved in Melanoma March 2022
A message of thanks from Matthew Browne, Melanoma Institute Australia CEO, to everyone involved in Melanoma March. Funds raised allow our Personalised Immunotherapy Platform (PIP) Clinical Trial to commence.